跳至主要内容
临床试验/NCT06906913
NCT06906913已完成不适用

Evaluation of Oropharyngeal and Anal Swab Samples in Patients With HPV Positivity

Medipol University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年3月14日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Oropharyngeal Swab Sample - HPV Testing

研究概览

简要总结

Patients whose pathology results are reported as cervical intraepithelial neoplasia (CIN) 1, CIN 2, and CIN 3, are recruited. We aimed to evaluate HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, by collecting oropharyngeal and anal swab samples. A total of 30 women of reproductive age, who consented to participate, were included in the study.

详细描述

Human papillomavirus (HPV) positivity is associated with cervical, oropharyngeal, and anal cancers. There is insufficient data in the current literature regarding the effectiveness of obtaining oropharyngeal and anal swabs from patients with HPV positivity is an effective method for detecting potential pathologies. HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3, will be evaluated by collecting oropharyngeal and anal swab samples.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • HPV-positive women presenting to the Obstetrics and Gynecology clinic, whose cervical pathology results were reported as CIN 1, CIN 2, and CIN 3

排除标准

  • HPV-negative women

结局指标

主要结局

Oropharyngeal Swab Sample - HPV Testing

时间窗: 1 month

Presence of HPV will be tested

Anal Swab Sample - HPV Testing

时间窗: 1 month

Presence of HPV

次要结局

  • Oropharyngeal Swab Sample - HPV Testing (if positive)(1 month)
  • Anal Swab Sample - HPV Testing (if positive)(1 month)

研究者

发起方
Medipol University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tugba Akcaoglu

Doctor of Medicine

Medipol University

研究点 (1)

Loading locations...

相似试验